Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
China flag China · Delayed Price · Currency is CNY
23.01
+0.04 (0.17%)
May 8, 2026, 3:04 PM CST

SHE:002287 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
2,4182,4162,3362,0402,0401,766
Other Revenue
--2.195.554.634.06
2,4182,4162,3382,0452,0451,770
Revenue Growth (YoY)
1.78%3.34%14.32%0.02%15.49%19.22%
Cost of Revenue
400.13409.47419.55324.7325.52269.7
Gross Profit
2,0182,0071,9181,7201,7191,501
Selling, General & Admin
1,2991,2851,2801,1621,107986.35
Research & Development
84.5181.0366.7358.6355.0970.82
Other Operating Expenses
-91.66-89.1134.7632.2629.4728.58
Operating Expenses
1,2921,2771,3821,2531,1921,084
Operating Income
726.32729.64536.7467.52527.71416.45
Interest Expense
---57.79-63.07-56.42-53.43
Interest & Investment Income
1.721.724.1941.9216.96340.33
Currency Exchange Gain (Loss)
---0.01-0.03-0.02-0.02
Other Non Operating Income (Expenses)
-39.32-64.28-0.02-1.16-3.56-2.46
EBT Excluding Unusual Items
688.72667.08483.08445.19484.68700.88
Impairment of Goodwill
------15.77
Gain (Loss) on Sale of Investments
65.3566.37100.3237.07-37.0820.69
Gain (Loss) on Sale of Assets
7.497.38-0.320-0.07
Asset Writedown
-1.71-0.98-0.58-0.3-1.22-0.35
Other Unusual Items
--63.43162.1472.8282.54
Pretax Income
759.85739.84646.24644.41519.2787.91
Income Tax Expense
93.5192.3764.8765.2449.5677.09
Earnings From Continuing Operations
666.34647.47581.37579.18469.64710.83
Minority Interest in Earnings
1.580.950.912.022.95.05
Net Income
667.92648.43582.28581.2472.54715.88
Net Income to Common
667.92648.43582.28581.2472.54715.88
Net Income Growth
19.17%11.36%0.19%22.99%-33.99%77.21%
Shares Outstanding (Basic)
552544530530530529
Shares Outstanding (Diluted)
552544530530530529
Shares Change (YoY)
4.12%2.50%0.03%-0.05%0.21%0.12%
EPS (Basic)
1.211.191.101.100.891.35
EPS (Diluted)
1.211.191.101.100.891.35
EPS Growth
14.46%8.64%0.15%23.05%-34.13%77.01%
Free Cash Flow
185.35576.63201.31458.5913.29909.35
Free Cash Flow Per Share
0.341.060.380.860.031.72
Dividend Per Share
--0.3800.4800.3900.590
Dividend Growth
---20.83%23.08%-33.90%73.53%
Gross Margin
83.45%83.05%82.06%84.12%84.08%84.77%
Operating Margin
30.04%30.20%22.96%22.86%25.81%23.52%
Profit Margin
27.62%26.84%24.91%28.42%23.11%40.43%
Free Cash Flow Margin
7.66%23.87%8.61%22.42%0.65%51.36%
EBITDA
868.74865.17644.7552.96604.13476.77
EBITDA Margin
35.92%35.81%27.57%27.04%29.54%26.93%
D&A For EBITDA
142.41135.5310885.4376.4260.32
EBIT
726.32729.64536.7467.52527.71416.45
EBIT Margin
30.04%30.20%22.96%22.86%25.81%23.52%
Effective Tax Rate
12.31%12.48%10.04%10.12%9.54%9.78%
Revenue as Reported
--2,3382,0452,0451,770
Source: S&P Global Market Intelligence. Standard template. Financial Sources.